Collegium Pharmaceutical Inc (COLL)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1,663,590 | 1,143,310 | 1,174,130 | 692,077 | 643,841 |
| Total stockholders’ equity | US$ in thousands | 228,842 | 195,431 | 194,842 | 202,928 | 186,031 |
| Financial leverage ratio | 7.27 | 5.85 | 6.03 | 3.41 | 3.46 |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,663,590K ÷ $228,842K
= 7.27
Collegium Pharmaceutical Inc's financial leverage ratio has shown some fluctuation over the past several years. It was 3.46 as of December 31, 2020, and decreased slightly to 3.41 by December 31, 2021. However, there was a notable increase to 6.03 by December 31, 2022, followed by a decrease to 5.85 by December 31, 2023. The ratio then increased significantly to 7.27 by December 31, 2024.
This indicates that the company's reliance on debt compared to equity has been varying significantly. A higher financial leverage ratio suggests a higher level of financial risk due to increased debt financing, while a lower ratio may indicate a more conservative capital structure. Collegium Pharmaceutical Inc should carefully monitor and manage this ratio to ensure a stable and sustainable financial position.
Peer comparison
Dec 31, 2024